Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

Pharmaceutical Market

Pharmaceutical News

Pharmaceutical Stocks

Pharmaceutical Market
Pharmaceutical News
Pharmaceutical Stocks

AbbVie Inc.

NYSE:ABBV:US

Featured Articles and Interviews

Feb 11, 2025

What is In-Licensing?

Jan 22, 2025

Biotech Market Forecast: Top Trends for Biotech in 2025

Jan 16, 2025

What are Dividend Stocks?

More Featured Articles and Inverviews

Press Releases

Mar 26, 2025

The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors

Mar 23, 2025

Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025

Mar 15, 2025

ELAHERE® Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients

More Press Releases

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Go Deeper

AI Powered

Microscopic view of stem cells.

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Pharmaceutical pills with dollar signs on them.

Top 10 Pharma Companies by Revenue

Interactive Chart

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.